Inhibition of carcinogen-bioactivating cytochrome P450 1 isoforms by amiloride derivatives. - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Biochemical Pharmacology Année : 2004

Inhibition of carcinogen-bioactivating cytochrome P450 1 isoforms by amiloride derivatives.

Lydie Sparfel
  • Fonction : Auteur correspondant
  • PersonId : 857503

Connectez-vous pour contacter l'auteur
Laurence Huc
Marc Le Vée
  • Fonction : Auteur
Mireille Desille
  • Fonction : Auteur
Dominique Lagadic-Gossmann
  • Fonction : Auteur
Olivier Fardel
  • Fonction : Auteur

Résumé

We examined the effects of amiloride derivatives, especially 5-(N-ethyl-N-isopropyl)amiloride (EIPA), on the activity of cytochrome P450 (CYP) 1 isoforms, known to metabolize carcinogenic polycyclic aromatic hydrocarbons (PAHs), such as benzo(a)pyrene (BP), into mutagenic metabolites and whose cellular expression can be induced through interaction of PAHs with the arylhydrocarbon receptor. EIPA was found to cause a potent and dose-dependent inhibition of CYP1-related ethoxyresorufine O-deethylase (EROD) activity in both liver cells and microsomes. It also markedly reduced activity of human recombinant CYP1A1 enzyme through a competitive mechanism; activities of other human CYP1 isoforms, i.e. CYP1A2 and CYP1B1, were also decreased. However, EIPA did not affect BP-mediated induction of CYP1A1 mRNA and protein levels in rat liver cells, likely indicating that EIPA does not block activation of the arylhydrocarbon receptor by PAHs. Inhibition of CYP1 activity by EIPA was associated with a decreased metabolism of BP, a reduced formation of BP-derived DNA adducts and a diminished BP-induced apoptosis in liver cells. The present data suggest that amiloride derivatives, such as EIPA, may be useful for preventing toxicity of chemical carcinogens, such as PAHs, through inhibition of CYP1 enzyme activity.
Fichier principal
Vignette du fichier
2004Sparfel-et-alBP_1.pdf (170.56 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02681620 , version 1 (31-05-2020)

Identifiants

Citer

Lydie Sparfel, Laurence Huc, Marc Le Vée, Mireille Desille, Dominique Lagadic-Gossmann, et al.. Inhibition of carcinogen-bioactivating cytochrome P450 1 isoforms by amiloride derivatives.. Biochemical Pharmacology, 2004, 67 (9), pp.1711-1719. ⟨10.1016/j.bcp.2004.01.005⟩. ⟨hal-02681620⟩
22 Consultations
110 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More